Increasing support for the next generation of clinical trials leaders by Peter Thompson et al.
LETTER Open Access
Increasing support for the next generation
of clinical trials leaders
Peter Thompson1* , James Fenton1, Lisa Cotterill1 and James P. Neilson2
Abstract
The National Institute for Health Research (NIHR) has identified a gap in the number of people it funds who are on
a pathway to become future leaders of clinical trials, compared to how much the NIHR invests in clinical trials. In
order to support the clinical trials of tomorrow, it is vital that the right people are supported now to lead these trials.
To address this issue, NIHR organised a workshop with key stakeholders to understand the barriers to embarking on a
clinical trials career and explore initiatives to increase capacity and capability in clinical trials. The output from
the workshop was a set of recommendations which NIHR is now considering to shape future support.
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Background
The National Institute for Health Research (NIHR) is
the research arm of the National Health Service (NHS)
in England. It is funded by the Department of Health in
order to deliver the Government’s strategy for applied
health research (http://www.nihr.ac.uk/about/). The
vision of the NIHR is, ‘To improve the health and wealth
of the nation through research’, and one of its aims in
order to realise this vision is to ‘Attract, develop and
retain the best research professionals to conduct people-
based research’. One of the main ways in which NIHR
does this is through its research training programmes
which are designed to create the applied health research
leaders of the future (www.nihr.ac.uk/funding/training-
programmes.htm). The NIHR does not provide training
(i.e. Masters courses, short courses) through these pro-
grammes; rather, it provides funding and support to
allow the best people to undertake excellent research
and extensive training and development programmes
based within high-calibre organisations. There are fund-
ing opportunities available for all professions, clinical
and non-clinical, from masters to professorial level.
These opportunities allow people to undertake research
training through doing research across a range of
disciplines and research methodologies. Training in
clinical trials represents an important area in which
people undertake training as part of an NIHR re-
search training award. Throughout this letter where
training in clinical trials is mentioned, this refers to
the training undertaken as part of a NIHR research
training award, not training provided directly by
NIHR. Details of the guidance currently given to ap-
plicants for NIHR research training awards can be
found within the latest application guidance notes
(e.g. http://www.nihr.ac.uk/documents/funding/Training-
Programmes/TCC-Fellowships-Guidance-Notes-2016.pdf).
Applicants to the NIHR research training programmes
often include a clinical trial, feasibility study or pilot
study, or other clinical trials training elements as part of
their proposed research and/or training and develop-
ment programme. Applicants are encouraged to work
with a Clinical Trials Unit (CTU) where appropriate and
must have the right level of trials experience in their
supervisory team. Applicants are also encouraged to
think about the scope of any trial or feasibility study in
relation to their research training award to ensure that it
is realistic to complete within the award timescale and
whether it represents a good training vehicle. However,
analysis of the NIHR training portfolio, by looking at the
type of research proposed within research training award
applications, has identified a gap in the number of
people undertaking trials training, with approximately
20 % of funded fellowships including a trial or feasibility
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study. This compares to 59 % of completed Research for
Patient Benefit (RfPB) grants being feasibility studies or
randomised controlled trials (RCTs) as of October 2013.
The RfPB programme represents a first opportunity for
many NIHR trainees to gain experience of applying for
and being awarded a significant research grant, and
whilst it is not necessarily expected that the profile of
research training awards in terms of research areas
(e.g. UKCRC Health Research Categories) and meth-
odologies (e.g. systematic review, feasibility study, co-
hort study) should exactly mirror that of the NIHR
research programmes, it is NIHR’s view that they
should broadly align. This will ensure that the profile
of new researchers who will become the research
leaders of tomorrow are able to match the require-
ments, in terms of skills and expertise, needed to de-
liver future NIHR research. Considering the amount
of investment by NIHR in RCTs (774 active RCTs in
May 2014 with a research cost of £880 million), it is
very important that NIHR trains the individuals capable of
leading trials in the future. To help understand barriers to
individuals undertaking trials training and to explore ini-
tiatives to increase capacity and capability in clinical trials
amongst trainees, NIHR set up a workshop with key
stakeholders which was held on 29 June 2015. Details of
the participants are given in Table 1 and were selected to
provide broad representation of the various interested par-
ties from NIHR, Department of Health, Clinical Trials
Units and other funders.
Workshop discussion
The aims of the workshop were to:
– Share the current provision for trainees interested in
a career as a clinical trialist
– Understand any barriers to trainees embarking on a
career in clinical trials
– Understand any barriers to institutions supporting
trainees involved in clinical trials
– Explore initiatives to increase capacity and capability
in clinical trials amongst NIHR trainees
The workshop heard views from across NIHR about
the current provision for clinical trials training and po-
tential ways forward, including the current provision of
research training awards and the viewpoints of a CTU
director, a current NIHR trainee, from NIHR’s research
programmes and the NIHR Clinical Research Network.
The discussion then focussed on how a trial fits into a
fellowship and whether this represents a good training
vehicle for someone interested in becoming a future tri-
als leader. Training awards which do include a clinical
trial primarily focus on feasibility studies and less on full
trials. A lot of discussion took place focussed on what a
fellowship based around clinical trials training should
look like; for example, some successful applicants have
used a fellowship to undertake a lot of the groundwork
and preparatory research before going onto to gain fur-
ther funding for a feasibility, pilot study or full trial. The
benefit of working with a CTU to gain experience in a
wide range of trial activities was also discussed.
The second part of the workshop was structured into
breakout groups to discuss the following points:
 Are training programmes fit for purpose?
 What does a career pathway look like?
 How do trainees/researchers move through the
NIHR pipeline?
Each of the breakout groups had a facilitator who re-
corded the key points from each discussion. Each group
nominated a spokesperson to feed back to the wider
group the key points recorded, which informed a further
Table 1 Names and affiliations of attendees at the NIHR Clinical
Trials Training workshop
Workshop attendees
Professor Jim Neilson—Dean for NIHR Faculty Trainees (Chair)
Professor Dave Jones—Dean for NIHR Faculty Trainees elect
Dr Lisa Cotterill—Director, NIHR Trainees Coordinating Centre
Dr Anthony Gordon—NIHR Clinician Scientist
Dr Carsten Flohr—NIHR Career Development Fellow
Professor Chris Hatton—Co-Director, RDS North West
Professor David Armstrong—RfPB Programme Director
Professor Deborah Ashby—Co-Director, Imperial Clinical Trials Unit
Professor Elaine McColl—Director, Newcastle Clinical Trials Unit
Dr Gillian Lancaster—Editor in Chief, Pilot and Feasibility Studies
Professor Hywel Williams—Chair, HTA Commissioning Board and HTA
Deputy Programme Director
Professor Ian Russell—Emeritus Professor of Clinical Trials
Professor Janet Peacock—Professor of Medical Statistics
Professor Jenny Hewison—Chair, HTA Monitoring Strategy Group
and former Chair, NIHR Career Development and Senior Research
Fellowships Panel
Professor Julia Brown—Director, Leeds Institute of Clinical Trials
Research and Chair, NIHR Doctoral Research Fellowships Panel
Ms Julie Bishop—Policy Manager, Sponsorship, Performance and
Workforce, Department of Health
Dr Liz Tremain, Senior Programme Manager, NIHR Trials Overview,
NETSCC
Professor Steve Smye, Theme Director, NIHR Clinical Research Network
Professor Tony Marson, Deputy Director, MRC North West Hub for
Trials Methodology Research
Dr Peter Thompson, Assistant Director, Personal Awards, NIHR TCC
Dr James Fenton, Assistant Director, Institutional Awards, NIHR TCC
Mr Tom Pratt, Programme Manager, Clinical Trials Fellowships, NIHR TCC
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discussion by the whole group. The meeting Chair facili-
tated these discussions, and recommendations were
agreed by consensus decision-making.
In looking at the training programmes, the workshop
concluded that work should be done to investigate pro-
viding more flexibility for people wanting to apply for a
NIHR Clinical Trials Fellowship (CTF). NIHR CTFs are
6-month fellowships open to already funded NIHR
trainees who are interested in undertaking an intense
period of clinical trials training in partnership with a CTU
following the conclusion of their current NIHR research
training award. The workshop also concluded that consid-
eration should be given to expanding the scope of the
NIHR Transitional Research Fellowship (TRF) to provide
a route into clinical trials for post-doctoral trainees with
little trials experience. NIHR TRFs are currently targeted
at researchers from a basic science background who want
to transition into applied health research and at
researchers returning from a significant career break.
Undertaking a TRF with focus on moving into clinical tri-
als could then put applicants in a strong position to apply
for further trials funding or fellowships, to lead on a small
feasibility study, for example. To ensure that training takes
place within a high-quality environment, encouragement,
or a requirement, to link with a CTU could be given. The
possibility of providing fellowships with explicit links to
already funded trials was also discussed.
In thinking about career pathways, the workshop
considered only those training to become future Chief In-
vestigators rather than the myriad of other roles involved
with clinical trials. It was agreed that a clear career pathway
for future Chief Investigators does not currently exist and
that career pathways for researchers who undertake trials
training is currently based more upon their clinical aca-
demic pathway (for clinician researchers). Expanding the
scope of the TRF as described above could help with this,
as would wider dissemination of case studies showcasing
people who have forged out a career in clinical trials.
Discussions around moving trainees through the NIHR
pathway focussed again on those training to become fu-
ture Chief Investigators. There was an agreement that
training awards should have a focus on feasibility and the
wider aspects of clinical trials so that trainees are in a
strong position to apply for trials funding in the future
from programmes like Health Technology Assessment
(HTA). The group also thought that developing some key
skills for those training in clinical trials would be helpful.
This could help, for example, someone wanting to put to-
gether a PhD programme with a focus on trials training.
Outcomes
The outcome of the workshop was a set of recommen-
dations that have been developed into a specific set of
proposals through a task and finish group which NIHR
set up following the workshop. These proposals are now
under consideration by NIHR, and any changes to re-
search training programmes as a result of these pro-
posals will be announced during course of 2016.
The original aims of the workshop had been to:
– Share the current provision for trainees interested in
a career as a clinical trialist
– Understand any barriers to trainees embarking on a
career in clinical trials
– Understand any barriers to institutions supporting
trainees involved in clinical trials
– Explore initiatives to increase capacity and capability
in clinical trials amongst NIHR trainees
The workshop represented a good opportunity to
present the current provision of research training oppor-
tunities provided by NIHR which allow for training in
clinical trials, and as a result of the discussions, several
potential barriers to people taking up these opportunities
emerged. These are summarised below:
 The timescale of a clinical trial does not necessarily
fit with that for a personal research training award.
 The additional staff and funds required to run a
large trial do not necessarily fit within the scope
of what can be provided by a personal research
training award.
 The additional time constraints associated with
registering for a PhD are not always compatible
with the timescales of a clinical trial.
 Undertaking a clinical trial or research on a trials-
related topic may not be as attractive to potential
PhD students as more traditional lab-based research.
 Applicants are not necessarily aware of how current
NIHR awards can be utilised to further skills and
experience in clinical trials.
 There is not a clear career pathway for researchers
looking to become future Chief Investigators.
 Additional flexibility may be required in some
schemes, particularly the CTF, to increase their
attractiveness to potential applicants.
The identification of potential barriers helped shape
the recommendations which came out of the workshop,
all of which were agreed upon with the aim of overcom-
ing these barriers and increasing capacity and capability
in clinical trials amongst NIHR trainees.
These recommendations are broadly summarised below:
– Increase flexibility and availability of training
programmes for clinical trials training
– Increase dissemination of opportunities for clinical
trials training
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– Explore linking trials training into the broader
research pathway
– Consider key skills for different stages of clinical
trials training
– Consider how research training awards can best
prepare trainees for a career as a trials leader when
developing recommendations into concrete
proposals
The task and finish group which developed these rec-
ommendations further was made up of a sub-section of
the attendees at the workshop reported here and worked
to the following terms of reference:
1. To develop proposals based upon the
recommendations of the NIHR Clinical Trials
Training workshop for future clinical trials training
within NIHR
2. To advise on the implementation of these proposals
within the current structure of NIHR research
training programmes
Whilst there are no plans to repeat the workshop re-
ported here, any changes that are implemented as a re-
sult of this workshop will be reviewed in the future and
where appropriate, and if required, further workshops
may be organised.
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